Literature DB >> 16813747

Long-term safety of an extended-cycle oral contraceptive (Seasonale): a 2-year multicenter open-label extension trial.

F D Anderson1, William Gibbons, David Portman.   

Abstract

OBJECTIVE: The purpose of this study was to assess the long-term safety of Seasonale, 91-day extended-cycle oral contraceptive (OC). STUDY
DESIGN: Following completion of a 1-year Phase 3 multicenter trial, patients from selected centers were invited to participate in this 2-year extension trial. In this open-label study all participants received the 91-day extended-regimen OC, Seasonale.
RESULTS: There were 189 study participants enrolled from 27 sites. Patient exposure included 1130 completed 91-day cycles. Overall rates of study discontinuation and the incidence of adverse events were similar to the earlier Phase 3 clinical trial. Seasonale was well tolerated and the number of reported bleeding and/or spotting days reported diminished during the course of the study.
CONCLUSION: This study confirms the findings from the previous clinical trial and demonstrates that Seasonale is a safe and effective therapy for long-term use.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16813747     DOI: 10.1016/j.ajog.2005.12.045

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  8 in total

1.  Clinical pharmacokinetic interactions between antiepileptic drugs and hormonal contraceptives.

Authors:  Doodipala Samba Reddy
Journal:  Expert Rev Clin Pharmacol       Date:  2010-03-01       Impact factor: 5.045

Review 2.  Contraception in Canada: a review of method choices, characteristics, adherence and approaches to counselling.

Authors:  William A Fisher; Amanda Black
Journal:  CMAJ       Date:  2007-03-27       Impact factor: 8.262

3.  Characteristics of scheduled bleeding manipulation with combined hormonal contraception in university students.

Authors:  Hannah Lakehomer; Paul F Kaplan; David G Wozniak; Christopher T Minson
Journal:  Contraception       Date:  2013-01-08       Impact factor: 3.375

4.  Susceptibility to nausea and motion sickness as a function of the menstrual cycle.

Authors:  Robert L Matchock; Max E Levine; Peter J Gianaros; Robert M Stern
Journal:  Womens Health Issues       Date:  2008-05-15

Review 5.  Clinical aspects of perimenstrual headaches.

Authors:  Frederick R Taylor
Journal:  Curr Pain Headache Rep       Date:  2009-02

6.  Safety, efficacy and patient satisfaction with continuous daily administration of levonorgestrel/ethinylestradiol oral contraceptives.

Authors:  Giuseppe Benagiano; Sabina Carrara; Valentina Filippi
Journal:  Patient Prefer Adherence       Date:  2009-11-03       Impact factor: 2.711

7.  Offering extended use of the combined contraceptive pill: a survey of specialist family planning services.

Authors:  Ulrike Sauer; Sue Mann; Nataliya Brima; Judith Stephenson
Journal:  Int J Womens Health       Date:  2013-09-30

Review 8.  Extended regimen combined oral contraception: A review of evolving concepts and acceptance by women and clinicians.

Authors:  Rossella E Nappi; Andrew M Kaunitz; Johannes Bitzer
Journal:  Eur J Contracept Reprod Health Care       Date:  2015-11-17       Impact factor: 1.848

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.